Kathleen M. Giacomini
Affiliations: | Biochemistry and Molecular Biology | University of California, San Francisco, San Francisco, CA |
Area:
Molecular Biology, Biochemistry, PharmacologyGoogle:
"Kathleen Giacomini"Children
Sign in to add traineeMark J. Dresser | grad student | 2000 | UCSF |
Karin M. Gerstin | grad student | 2001 | UCSF |
Maya K. Leabman | grad student | 2002 | UCSF |
Lara M. Mangravite | grad student | 2002 | UCSF |
Ilaria Badagnani | grad student | 2006 | UCSF |
Ryan P. Owen | grad student | 2006 | UCSF |
Marco D. Sorani | grad student | 2007 | UCSF |
Thomas J. Urban | grad student | 2007 | UCSF |
Cheryl D. Cropp | grad student | 2008 | UCSF |
Debbie W. Lin | grad student | 2008 | UCSF |
Shuanglian Li | grad student | 2010 | UCSF |
James E. Shima | grad student | 2011 | UCSF |
Ethan G. Geier | grad student | 2013 | UCSF |
Kari M. Morrissey | grad student | 2013 | UCSF |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Asano S, Galetin A, Tomita Y, et al. (2025) Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium). Clinical Pharmacology and Therapeutics |
Giacomini KM. (2025) Leading the Way: Multi-Drug Resistance Protein (MDR1) and Clinical Pharmacology-Commentary on Kim et al. Clinical Pharmacology and Therapeutics. 117: 1562-1576 |
Riselli AM, Yee SW, Yang J, et al. (2025) Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2). Clinical Pharmacology and Therapeutics |
Yee SW, Wang J, Giacomini KM. (2024) Rare Diseases Linked to Mutations in Vitamin Transporters Expressed in the Human Blood-Brain Barrier. Clinical Pharmacology and Therapeutics |
Yee SW, Ferrández-Peral L, Alentorn-Moron P, et al. (2024) Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates. Nature Communications. 15: 4380 |
Yee SW, Macdonald CB, Mitrovic D, et al. (2024) The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics. Molecular Cell |
Galetin A, Brouwer KLR, Tweedie D, et al. (2024) Membrane transporters in drug development and as determinants of precision medicine. Nature Reviews. Drug Discovery |
Yee SW, Ferrández-Peral L, Alentorn P, et al. (2023) Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates. Research Square |
Michel ME, Wen CC, Yee SW, et al. (2023) TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters. Clinical Pharmacology and Therapeutics |
Yee SW, Ferrández-Peral L, Alentorn P, et al. (2023) Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates. Biorxiv : the Preprint Server For Biology |